Literature DB >> 21116949

Unique benefits of nanotechnology to drug delivery and diagnostics.

Scott E McNeil1.   

Abstract

Nanotechnology offers many potential benefits to medical research by making pharmaceuticals more efficacious and by decreasing their adverse side-effects. Preclinical characterization of nanoparticles intended for medical applications is complicated--due to the variety of materials used, their unique surface properties and multifunctional nature. This chapter serves as an introduction to the volume, giving a broad overview of applications of nanotechnology to medicine, and describes some of the beneficial aspects of nanotechnology-based drug delivery. We define nanotechnology and provide brief descriptions of the major classes of nanomaterials used for medical applications. The following two chapters discuss scientific and regulatory hurdles involved in the use of nanotechnology in medicine. The remaining bulk of the volume provides the reader with protocols that have been tested against clinically relevant nanoparticles and describes some of the nuances of nanoparticle types and necessary controls.

Mesh:

Substances:

Year:  2011        PMID: 21116949     DOI: 10.1007/978-1-60327-198-1_1

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  27 in total

Review 1.  The role of nanotechnology in the treatment of viral infections.

Authors:  Lavanya Singh; Hendrik G Kruger; Glenn E M Maguire; Thavendran Govender; Raveen Parboosing
Journal:  Ther Adv Infect Dis       Date:  2017-07-05

Review 2.  Informatics and standards for nanomedicine technology.

Authors:  Dennis G Thomas; Fred Klaessig; Stacey L Harper; Martin Fritts; Mark D Hoover; Sharon Gaheen; Todd H Stokes; Rebecca Reznik-Zellen; Elaine T Freund; Juli D Klemm; David S Paik; Nathan A Baker
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2011-06-30

3.  Real-time analysis of composite magnetic nanoparticle disassembly in vascular cells and biomimetic media.

Authors:  Jillian E Tengood; Ivan S Alferiev; Kehan Zhang; Ilia Fishbein; Robert J Levy; Michael Chorny
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-03       Impact factor: 11.205

Review 4.  Managing diabetes with nanomedicine: challenges and opportunities.

Authors:  Omid Veiseh; Benjamin C Tang; Kathryn A Whitehead; Daniel G Anderson; Robert Langer
Journal:  Nat Rev Drug Discov       Date:  2014-11-28       Impact factor: 84.694

Review 5.  Complex effects of tumor microenvironment on the tumor disposition of carrier-mediated agents.

Authors:  Andrew T Lucas; Lauren Sl Price; Allison Schorzman; William C Zamboni
Journal:  Nanomedicine (Lond)       Date:  2017-07-26       Impact factor: 5.307

6.  Nanoparticle-mediated delivery of a rapidly activatable prodrug of SN-38 for neuroblastoma therapy.

Authors:  Ivan S Alferiev; Radhika Iyer; Jamie L Croucher; Richard F Adamo; Kehan Zhang; Jennifer L Mangino; Venkatadri Kolla; Ilia Fishbein; Garrett M Brodeur; Robert J Levy; Michael Chorny
Journal:  Biomaterials       Date:  2015-02-16       Impact factor: 12.479

Review 7.  Local delivery strategies to restore immune homeostasis in the context of inflammation.

Authors:  Elizabeth R Bentley; Steven R Little
Journal:  Adv Drug Deliv Rev       Date:  2021-09-13       Impact factor: 15.470

Review 8.  RNA interference for glioblastoma therapy: Innovation ladder from the bench to clinical trials.

Authors:  Eunice L Lozada-Delgado; Nilmary Grafals-Ruiz; Pablo E Vivas-Mejía
Journal:  Life Sci       Date:  2017-08-31       Impact factor: 5.037

9.  Nanoinformatics knowledge infrastructures: bringing efficient information management to nanomedical research.

Authors:  D de la Iglesia; R E Cachau; M García-Remesal; V Maojo
Journal:  Comput Sci Discov       Date:  2013-11-27

Review 10.  Nanotechnological approaches for the development of herbal drugs in treatment of diabetes mellitus - a critical review.

Authors:  Saritha Marella; Naga Venkata Krishna Vara Prasad Tollamadugu
Journal:  IET Nanobiotechnol       Date:  2018-08       Impact factor: 1.847

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.